Natural and induced tolerogenic dendritic cells

CA Iberg, D Hawiger - The Journal of Immunology, 2020 - journals.aai.org
Dendritic cells (DCs) are highly susceptible to extrinsic signals that modify the functions of
these crucial APCs. Maturation of DCs induced by diverse proinflammatory conditions …

Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

JT Haas, L Vonghia, DA Mogilenko, AN Verrijken… - Nature …, 2019 - nature.com
Progression of fatty liver to non-alcoholic steatohepatitis (NASH) is a rapidly growing health
problem. The presence of inflammatory infiltrates in the liver and hepatocyte damage …

[HTML][HTML] Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating …

D Wang, Q Cui, YJ Yang, AQ Liu, G Zhang… - Biomedicine & …, 2022 - Elsevier
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) that are essential in
mediating the body's natural and adaptive immune responses. The body can regulate the …

cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1

ST Ferris, RA Ohara, F Ou, R Wu, X Huang, S Kim… - Cancer immunology …, 2022 - AACR
As a cell-based cancer vaccine, dendritic cells (DC), derived from peripheral blood
monocytes or bone marrow (BM) treated with GM-CSF (GMDC), were initially thought to …

Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal

A Baranska, A Shawket, M Jouve, M Baratin… - Journal of Experimental …, 2018 - rupress.org
Here we describe a new mouse model that exploits the pattern of expression of the high-
affinity IgG receptor (CD64) and allows diphtheria toxin (DT)–mediated ablation of tissue …

Dendritic cells, the T-cell-inflamed tumor microenvironment, and immunotherapy treatment response

CS Garris, JJ Luke - Clinical Cancer Research, 2020 - AACR
The development of the most successful cancer immunotherapies in solid tumors, immune-
checkpoint blockade, has focused on factors regulating T-cell activation. Until recently, the …

[HTML][HTML] MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity

TE Pankhurst, KH Buick, JL Lange, AJ Marshall… - Cell Reports, 2023 - cell.com
Protective immune responses against respiratory pathogens, such as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus, are initiated by the …

The role of B cell antigen presentation in the initiation of CD4+ T cell response

Z Hua, B Hou - Immunological reviews, 2020 - Wiley Online Library
B cells have been known for their ability to present antigens to T cells for almost 40 years.
However, the precise roles of B cell antigen presentation in various immune responses are …

[HTML][HTML] Targeting TMEM176B enhances antitumor immunity and augments the efficacy of immune checkpoint blockers by unleashing inflammasome activation

M Segovia, S Russo, M Jeldres, YD Mahmoud, V Perez… - Cancer cell, 2019 - cell.com
Although immune checkpoint blockers have yielded significant clinical benefits in patients
with different malignancies, the efficacy of these therapies is still limited. Here, we show that …

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

Y Zhu, Z Wu, W Yan, F Shao, B Ke, X Jiang… - EMBO Molecular …, 2022 - embopress.org
Psoriasis is a complex chronic inflammatory skin disease with unclear molecular
mechanisms. We found that the Src homology‐2 domain‐containing protein tyrosine …